18850 - Human Photoallergy Test
NCT02751463 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2018-12-13
Summary
To evaluate the potential of a test material to produce a photoallergic response.
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
Sunscreening Sport Spray Rest (BAY987519)
50 μl/ cm\*2 of the test article is applied directly to two sites on the skin and covered with the appropriate patch. 24 hours later, the patches are removed. The test sites are lightly wiped with a dry cloth/tissue and 3μl/ cm2 of test article is reapplied directly to the skin of the test site designated for irradiation, and lightly spread over the test site. 48 hours later the procedure is repeated to the same test sites. This process is repeated twice weekly for a total of six exposures.(Formulation Number - RB# Y51-002 )
- OTHER
-
Untreated skin
One site is patched without treatment as control
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-09
- Primary Completion
- 2016-07-01
- Completion
- 2016-07-01
Countries
- United States
Study Locations
More Related Trials
-
Human Photoallergy Test
NCT02751515 ·Status: COMPLETED ·Phase: NA
-
18348-Human Phototoxicity Test
NCT02823483 ·Status: COMPLETED ·Phase: NA
-
To Test for Photo Allergy Reaction of Sunscreens
NCT02872220 ·Status: COMPLETED ·Phase: NA
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
Substance P Challenge in Healthy Participants
NCT04676763 ·Status: COMPLETED ·Phase: NA
-
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
NCT02117739 ·Status: COMPLETED ·Phase: PHASE1
-
Photopatch Test Study (POST Study)
NCT03812887 ·Status: UNKNOWN
-
Dermal Photo Allergic Skin Reaction
NCT04070755 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT03015103 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Safety Study of New Sinecort Formulation Versus Positive Control
NCT00885937 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT02441608 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
NCT00640614 ·Status: COMPLETED ·Phase: PHASE3
-
21 Day Cumulative Skin Irritation of RUT058-60
NCT02198963 ·Status: COMPLETED ·Phase: PHASE1
-
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
NCT01085851 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
NCT01518348 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
NCT07181369 ·Status: RECRUITING ·Phase: PHASE1
-
Multi-Centre European Photopatch Test Study
NCT00530387 ·Status: COMPLETED ·Phase: NA
-
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
NCT04853823 ·Status: UNKNOWN ·Phase: PHASE1
-
Human Repeated Insult Patch Test
NCT03474874 ·Status: COMPLETED ·Phase: NA
-
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
NCT04624867 ·Status: UNKNOWN ·Phase: PHASE1
-
SPT for Sensitization of Collagen Dressing
NCT06271993 ·Status: COMPLETED ·Phase: NA
-
Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results
NCT06872996 ·Status: RECRUITING ·Phase: NA
-
Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
NCT04807751 ·Status: COMPLETED ·Phase: PHASE1